Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Key Information
Due Date: Not Specified
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Forecasted
Contact Info:
terrin.brown@fda.hhs.gov
Terrin Brown Grantor 2404027610
Terrin Brown Grantor 2404027610
Overview
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
Show More
Additional Info
Posted Date: August 14, 2024
Application Due Date: Not Specified
Estimated Award Date: Not Specified
Eligible Applicants:
- Special district governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities/Indian housing authorities
- Unrestricted
- Independent school districts
- Native American tribal organizations (other than Federally recognized tribal governments)
- State governments
- Small businesses
- Native American tribal governments (Federally recognized)
- City or township governments
- Private institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- County governments
- For profit organizations other than small businesses
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
